TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

Impressive roster of presenters - good company to be networking with.

I sense your knowledge of biotechnology is far above my self researching / logical investigative analysis.

Here's a question i have that perhaps you may have insight on.

Could TScan's TargetScan and ReceptorScan be potentially used, as a standard of care procedure, to first determine what antigens the patient's cancer has? Wouldn't this provide insight into what treatment the patient would be most suitable for?

I ask this because of certain processes i have seen individuals go through, only to pass away.

Here's an example: patient is diagnosed with metastasized cancer and is prescribed chemo+Keytruda. 4 months later it is determined that nothing is working, Keytruda had no benefit ( no receptor/antigen match, imo) chemo weakens patient/cancer gains strength/patient dies.

TScan's Target/Receptor scan approach to cancer treatment makes logical sense, imo.

I'm not exactly sure on the standard of care procedures for cancer that are already in place, however if TScan's Target/Receptor Scan were to become standard of care procedure, this would certainly be an incredibly vital asset for TCRX.